Search Results - "Bouchla, A."

Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study by Chatzileontiadou, S, Hatjiharissi, E, Angelopoulou, M, Asimakopoulos, J V, Loutsidi, N E, Chatzikonstantinou, T, Zikos, P, Bouchla, A, Bezirgiannidou, Z, Kouvata, E, Frouzaki, C, Chaloudis, P, Sotiropoulos, D, Douka, V, Sirigou, A, Mandala, E, Psyllaki, M, Papadaki, H A, Marinakis, T, Viniou, N A, Kokkori, S, Kontopidou, F, Skepetari, A, Vassilopoulos, G, Kotsianidis, I, Pappa, V, Lalayanni, C, Baltadakis, I, Delimpassi, S, Pagoni, M, Papaioannou, M

“…Thrombosis is the most common and a life-threatening complication in patients with Paroxysmal Nocturnal Hemoglobinuria. One-third of patients with PNH…”
Get full text

PB1917: PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF ELEMENTS OF THE ADAPTIVE IMMUNITY IN THE MICROENVIRONMENT OF MYELODYSPLASTIC SYNDROMES TREATED WITH 5‐AZACITIDINE by Tsakiraki, Z., Papageorgiou, S., Spathis, A., Pouliakis, A., Bouchla, A., Thomopoulos, T., Panayiotides, I. G., Pappa, V., Foukas, P.

Get full text

PB1787: GADD45A IS OVER‐EXPRESSED IN THE BONE MARROW OF PATIENTS WITH DE NOVO ACUTE MYELOID LEUKEMIA REFRACTORY TO INDUCTION CHEMOTHERAPY by Bouchla, A., Deliconstantinos, G., Loupis, T., Kontsioti, F., Mpakou, V., Delatola, M., Pagoni, M., Theodorakopoulos, K., Papageorgiou, S., Pappa, V.

Get full text

Immune Cell Density as a Predictive Index for Response to Treatment and Outcome of High Risk MDS Treated with 5-Azacytidine by Tsakiraki, Z, Papageorgiou, S, Spathis, A, Bouchla, A, Bazani, E, Glezou, E, Karakitsos, P, Panayiotides, I, Pappa, V, Foukas, P

Get full text

P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID‐19: RESULTS OF A MULTICENTER PHASE II TRIAL by Thomopoulos, T., Bouchla, A., Antoniadou, A., Terpos, E., Politou, M., Stamoulis, K., Koromboki, E., Papageorgiou, S., Kotanidou, A., Kalomenidis, I., Jahaj, E., Grigoropoulou, S., Pagoni, M., Grouzi, E., Poulakou, G., Trontzas, I., Labropoulou, S., Mentis, A., Bamias, A., Tsiodras, S., Dimopoulos, M.‐A., Pappa, V.

Get full text

PB1936: PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND THROMBOSIS: A MULTICENTRIC RETROSPECTIVE STUDY by Chatzileontiadou, S., Loutsidi, N.‐E., Asimakopoulos, I., Chatzikonstantinou, T., Zikos, P., Bouchla, A., Bezirgiannidou, Z., Kouvata, E., Apsemidou, A., Frouzaki, C., Hatjiharissi, E., Chaloudis, P., Sotiropoulos, D., Douka, V., Syrigou, A., Mandala, E., Psyllaki, M., Papadaki, H., Marinakis, T., Viniou, N.‐A., Kokori, S., Vassilopoulos, G., Kotsianidis, I., Pappa, V., Pagoni, M., Lalayanni, C., Anagnostopoulos, A., Baltadakis, I., Delimpassi, S., Angelopoulou, M., Papaioannou, M.

Get full text

P01-306 - Trait anxiety predicts quality of life in patients with heart failure independently of the severity of disease by Samartzis, L, Dimopoulos, S, Manetos, C, Agapitou, V, Bouchla, A, Tasoulis, A, Drakos, S, Terrovitis, J, Nanas, S

“…Objectives The objective of this study was to investigate the relationship between anxiety personality trait, Quality of Life (QoL) and severity of disease in…”
Get full text

Topic: AS08-Treatment/AS08b-Current treatment options – Lower risk MDS: LUSPATERCEPT IN THE TREATMENT OF MDS PATIENTS. A SINGLE CENTER EXPERIENCE by Bouchla, A., Thomopoulos, T., Loucari, C., Apostolopoulou, C., Vryttia, P., Zorba, A., Gkondopoulos, K., Papageorgiou, S., Pappa, V.

Get full text

The utility of multiparametric ultrasonography combined with selective core-needle biopsy in detecting lymph node involvement in mycosis fungoides by Lampadaki, K, Vaiopoulos, A, Bizimi, V, Filippiadis, D, Grigoriadis, S, Koumourtzis, M, Nikolaou, V, Bouchla, A, Tsirigotis, P, Pappa, V, Marinos, L, Papadavid, E

Get full text

Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: NOVEL PREDICTIVE INDICATORS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC NEOPLASMS (HR-MDS) TREATED WITH 5-AZACYTIDINE: CUMULATIVE DATA FROM THE HELLENIC MDS STUDY GROUP by Kotsianidis, I., Hatzimichael, E., Pappa, V., Galanopoulos, A., Kourakli, A., Diamantopoulos, P., Papageorgiou, S., Liapis, K., Papadopoulos, V., Papoutselis, M., Bouchla, A., Georgoulis, V., Vassilakopoulos, T., Solomou, E., Dimou, M., Vassilopoulos, G., Vardi, A., Papaioannou, M., Pontikoglou, C., Anagnostopoulos, A., Panayiotidis, P., Kontopidou, F., Harchalakis, N., Adamopoulos, N., Ximeri, M., Zikos, P., Megalakaki, A., Repousis, P., Kotsopoulou, M., Dryllis, G., Tsoukanas, D., Kyrtsonis, M.-C., Poulakidas, E., Bouronikou, E., Delimpasis, S., Mparmparousi, D., Papadaki, H., Vyniou, N.A., Symeonidis, A.

Get full text

182 - Immune Cell Density as a Predictive Index for Response to Treatment and Outcome of High Risk MDS Treated with 5-Azacytidine by Tsakiraki, Z., Papageorgiou, S., Spathis, A., Bouchla, A., Bazani, E., Glezou, E., Karakitsos, P., Panayiotides, I., Pappa, V., Foukas, P.

Get full text

PB2058 THE PROGNOSTIC ROLE OF MYOCYTE‐SPECIFIC ENHANCER FACTOR 2 C (MEF2 C) IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMAS (DLBCL) by Anastasiou, M., Tsakiraki, Z., Spathis, A., Bouchla, A., Papageorgiou, S., Panayiotides, I., Pappa, V., Foukas, P.

“…Background: DLBCL is the most common subtype of non‐Hodgkin's lymphomas. However, the pathogenesis of DLBCL is not fully understood. Transcription factors or…”
Get full text

The Addition of Strength Training to Aerobic Interval Training: Effects on Muscle Strength and Body Composition in CHF Patients

Get full text